Nobel laureates: Despite progress, cancer won't be wiped out
The winners of this year's Nobel Prize for Medicine say they expect substantial advances toward treating cancer in the next several decades although it is unlikely the disease could be eradicated (Source: ABC News: Health)
Source: ABC News: Health - December 6, 2018 Category: Consumer Health News Tags: Health Source Type: news

Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA ’ s new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products
Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA ’ s new effort for developing and class labeling of vitro companion diagnostics for classes of oncology therapeutic products (Source: Food and Drug Administration)
Source: Food and Drug Administration - December 6, 2018 Category: American Health Source Type: news

Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA ’s new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products
Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA ’s new effort for developing and class labeling of vitro companion diagnostics for classes of oncology therapeutic products (Source: Food and Drug Administration)
Source: Food and Drug Administration - December 6, 2018 Category: American Health Source Type: news

ASH Poster Rounds: Obesity Impacts CLL Survival in Women
(MedPage Today) -- Plus: New risk model predicts CLL survival; novel BTK inhibitor works after ibrutinib (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 6, 2018 Category: Hematology Source Type: news

Obesity May Be Driving Rise in Uterine Cancers
THURSDAY, Dec. 6, 2018 -- Cases of uterine cancer are charting a slow but steady rise among American women, and so are deaths from the disease, new statistics show. Looking at federal health data, researchers from the U.S. Centers for Disease... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 6, 2018 Category: General Medicine Source Type: news

Morning Break: #MeToo at Columbia; Cancer Test Hype; With Child, in Chains
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 6, 2018 Category: American Health Source Type: news

Tamoxifen at a Lower Dose Might Still Prevent Breast Cancer's Return
THURSDAY, Dec. 6, 2018 -- Tamoxifen is considered a vital weapon in the fight against breast cancer, but many women who have to take the drug struggle with its significant side effects. Now, new research shows that a lower dose of the hormone... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 6, 2018 Category: General Medicine Source Type: news

Kidney Disease Claiming More Lives
THURSDAY, Dec. 6, 2018 -- Although fewer Americans are dying from heart disease and cancer, deaths from chronic kidney disease are on the rise, especially among young adults, a new study finds. " Unfortunately, chronic kidney disease is known as a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 6, 2018 Category: General Medicine Source Type: news

SABCS: Low-Dose Tamoxifen Cuts Risk for Breast Dz
THURSDAY, Dec. 6, 2018 -- Tamoxifen at a dose of 5 mg/day is associated with a reduced risk for recurrence for women with hormone-sensitive breast intraepithelial neoplasia, according to a study presented at the annual San Antonio Breast Cancer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 6, 2018 Category: Pharmaceuticals Source Type: news

Full-time post-doctoral research position available at Baylor College of Medicine
Applications are open for a full-time Postdoctoral Associate position available immediately in theMitsiades lab at Baylor College of Medicine to study the role of steroid receptors in prostate and breast cancer. Deadline for applications is1 March 2019.Interested candidates should submit their CV, a cover letter explaining their relevant work experience, and 3 names of references toNicholas Mitsiades. (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 6, 2018 Category: Endocrinology Source Type: news

Cancer warning: Four of the most common warning signs of cancer you may be overlooking
CANCER symptoms vary depending on which part of the body is affected by a tumour. You could be at risk of a tumour if you have weight loss or unexplained pain. These are the most common signs of cancer that you may be overlooking. (Source: Daily Express - Health)
Source: Daily Express - Health - December 6, 2018 Category: Consumer Health News Source Type: news

FDA grants priority review to Roche's Tecentriq in combination with chemotherapy for the initial treatment of extensive-stage small cell lung cancer
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the US Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq® (atezolizumab), in combination with carboplatin and etoposide (chemotherapy), for the initial (first-line) treatment of people with extensive-stage small cell lung cancer (ES - SCLC). (Source: World Pharma News)
Source: World Pharma News - December 6, 2018 Category: Pharmaceuticals Tags: Featured Roche Business and Industry Source Type: news

Uganda: Cancer Institute Imposes New Charges On Patients
[Monitor] Kampala -The Uganda Cancer Institute (UCI) has started charging Shs300,000 for patients seeking radiotherapy treatment, which was previously free-of-charge. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 6, 2018 Category: African Health Source Type: news

Many Americans Unaware of Promise of Targeted,'Personalized' Medicine: Poll
THURSDAY, Dec. 6, 2018 -- Medical science has made tremendous advances in " personalized medicine " -- drugs that fight cancer and other diseases by boosting the immune system or targeting specific genetic traits. Former U.S. President Jimmy Carter... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 6, 2018 Category: General Medicine Source Type: news

Fewer Early Stage Breast Cancer Patients May Need Lymph Node Removal: Study
THURSDAY, Dec. 6, 2018 -- For many breast cancer patients, removal of lymph nodes in the armpit area is a common procedure, due to worries that the tumor has spread to these tissues. But the operation can also bring the difficult long-term side... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 6, 2018 Category: General Medicine Source Type: news

Women could be offered DIY smear test kits in order to boost cervical cancer screening  
Cervical cancer screening in Britain has fallen to an all-time low - with figures last week revealing nearly five million women now overdue for testing. (Source: the Mail online | Health)
Source: the Mail online | Health - December 6, 2018 Category: Consumer Health News Source Type: news

Augmedix & apos;s EHR Documentation Platform Enters Innovative Pilot With Award-Winning iKnowMed Oncology EHR
LAS COLINAS, TEXAS and SAN FRANCISCO, December 6, 2018 —McKesson Corporation, which has been investing in technologies and services that create more efficiencies for healthcare providers, and Augmedix, a technology-enabled service for health systems and providers, announced the expansion of an innova... (Source: McKesson News)
Source: McKesson News - December 6, 2018 Category: Information Technology Source Type: news

New pediatric chief helps bring science fiction to life
Dr. Steven Lipshultz brings a long career in pediatric oncology the Buffalo as the new chief of peds at John R. Oishei Children ’s Hospital, as well as research dollars in population health and heart care. He talked to Buffalo Business First about what brought him here from Michigan. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 6, 2018 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

Too Much Time in the Sun? Skin Patch Might Tell
Title: Too Much Time in the Sun? Skin Patch Might TellCategory: Health NewsCreated: 12/5/2018 12:00:00 AMLast Editorial Review: 12/6/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 6, 2018 Category: Cancer & Oncology Source Type: news

Fewer Early Stage Breast Cancer Patients May Need Lymph Node Removal: Study
Title: Fewer Early Stage Breast Cancer Patients May Need Lymph Node Removal: StudyCategory: Health NewsCreated: 12/6/2018 12:00:00 AMLast Editorial Review: 12/6/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 6, 2018 Category: Cancer & Oncology Source Type: news

Worldwide Search For Donors to Help Girl With Rare Blood Type
Title: Worldwide Search For Donors to Help Girl With Rare Blood TypeCategory: Health NewsCreated: 12/6/2018 12:00:00 AMLast Editorial Review: 12/6/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 6, 2018 Category: Cancer & Oncology Source Type: news

Many Americans Unaware of Promise of Targeted, 'Personalized' Medicine: Poll
Title: Many Americans Unaware of Promise of Targeted, 'Personalized' Medicine: PollCategory: Health NewsCreated: 12/6/2018 12:00:00 AMLast Editorial Review: 12/6/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 6, 2018 Category: Cancer & Oncology Source Type: news

DBT betters mammo performance in screening, diagnosis
Digital breast tomosynthesis (DBT) improves upon mammography's performance...Read more on AuntMinnie.comRelated Reading: Ultrasound after DBT obviates diagnostic 2D mammo DBT maintains high performance over time DBT doesn't hurt screening throughput DBT spots 34% more breast cancers than mammography DBT plus ABVS offers a breast cancer staging alternative (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 6, 2018 Category: Radiology Source Type: news

FDA clears Elekta's Unity MR radiation therapy system
Radiation oncology vendor Elekta has received 510(k) premarket approval from...Read more on AuntMinnie.comRelated Reading: Elekta highlights Unity abstracts at ASTRO Elekta acquires software firm Acumyn York Instruments buys Elekta's MEG business Elekta partners with NY cancer center on radiation therapy China clears Elekta's Gamma Knife Icon (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 6, 2018 Category: Radiology Source Type: news

A mechanistic approach to neuroblastoma prognosis and risk
(American Association for the Advancement of Science) A new study reveals key molecular indicators that could help doctors select the best form of treatment for patients with neuroblastoma -- the most common type of cancer in infants. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

The naked eye alone is not enough to ensure the accurate diagnosis of skin cancer, say experts
(University of Birmingham) The visual inspection of a suspicious skin lesion using the naked eye alone is not enough to ensure the accurate diagnosis of skin cancer, a group of experts have concluded. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Black breast cancer patients have worse outcomes than whites, despite similar treatments
(Loyola University Health System) Black women with the most common form of early breast cancer had worse outcomes than white women even after receiving equivalent care, according to a major new study led by Loyola Medicine medical oncologist Kathy Albain. Dr. Albain presented findings of the international study at the San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Scientists to produce anti-cancer drugs in yeast
(Technical University of Denmark) New UN rules avert the production of therapeutic drugs formulated on naturally occurring plant molecules. A new research project will rescue the production by producing natural drugs sustainably in baker's yeast. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 6, 2018 Category: Biology Source Type: news

Black women have worse breast cancer outcomes despite receiving similar treatment as white women
(American Association for Cancer Research) Even with equivalent treatments in women with hormone receptor-positive, HER2-negative breast cancer, black women had significantly higher breast cancer recurrence and increased overall mortality compared to white women in a large phase III clinical trial, TAILORx, according to data presented at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 6, 2018 Category: International Medicine & Public Health Source Type: news

'Chemo brain' caused by malfunction in three types of brain cells, Stanford study finds
(Stanford Medicine) In a new study explaining the cellular mechanisms behind cognitive impairment from chemotherapy, scientists at the Stanford University School of Medicine have demonstrated that a widely used chemotherapy drug, methotrexate, causes a complex set of problems in three major cell types within the brain's white matter. The study, which will be published online Dec. 6 in Cell, also identifies a potential remedy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Circulating tumor cell count could help choose treatment for metastatic breast cancer patients
(American Association for Cancer Research) Circulating tumor-cell (CTC) count could be used to choose hormone therapy or chemotherapy as frontline treatment for patients with estrogen receptor-positive (ER+), HER2-negative (HER2-) metastatic breast cancer, according to data from the phase III STIC CTC clinical trial presented at the 2018 San Antonio Breast Cancer Symposium. In the case of discrepancy between CTC count-based treatment choice and physician's choice of treatment, frontline chemotherapy was associated with a significant gain in overall survival. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Low-dose tamoxifen reduced recurrence and new disease for patients with DCIS, LCIS, and ADH
(American Association for Cancer Research) Treatment with a low dose of tamoxifen (5 mg per day) halved the risk of disease recurrence and new disease for women who had been treated with surgery following a diagnosis of breast intraepithelial neoplasia compared with placebo, and it did not cause more serious adverse events, according to data from the randomized, phase III TAM-01 clinical trial presented at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Liquid biopsies in SOLAR-1 trial predict benefit of Alpelisib in PIK3CA-mutant breast cancer
(American Association for Cancer Research) Liquid biopsy-based assessment of PIK3CA mutational status served as a better indicator of progression-free survival compared with analysis of tissue biopsy in breast cancer patients enrolled in the phase III clinical trial SOLAR-1, according to data presented at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Axillary RT and lymph node surgery yielded comparable outcomes for patients with breast cancer
(American Association for Cancer Research) Patients with early-stage breast cancer who had cancer detected in a sentinel lymph node biopsy had comparable 10-year recurrence and survival rates following either axillary radiotherapy or axillary lymph node dissection, according to data from the randomized, phase III AMAROS clinical trial presented at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Putting the brakes on tumor stealth
(Monash University) New research undertaken at Monash University has shed new light on how some cancers are able to escape our immune system. The findings have significant implications for the burgeoning field of cancer immunotherapy, an approach that is focused on harnessing the remarkable power of our own immune system to seek out and destroy cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

New molecular tool identifies sugar-protein attachments
(Johns Hopkins Medicine) Researchers at Johns Hopkins Medicine have developed a new molecular tool they call EXoO, which decodes where on proteins specific sugars are attached -- a possible modification due to disease. The study, published in issue 14 of Molecular Systems Biology, describes the development of the tool and its successful use on human blood, tumors and immune cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Michael Hall wins Charles Rodolphe Brupbacher Prize for Cancer Research 2019
(University of Zurich) Michael Hall of the Biozentrum of the University of Basel is awarded the Charles Rodolphe Brupbacher Prize for Cancer Research 2019. The prize recognizes his discovery of the TOR enzyme which controls cell growth via a complex signalling network. His work has made a key contribution to the development of new cancer drugs. The award ceremony will take place on Jan. 31, 2019 in Zurich. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

University of Maryland doctors treat first breast cancer patients with GammaPod radiotherapy
(University of Maryland Medical Center) Radiation oncologists at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) are now treating patients with the GammaPod ™ , a new FDA-cleared radiation therapy for early-stage breast cancer. The UMGCCC is the first site to treat patients with this first-of-its-kind system, which was invented by University of Maryland School of Medicine (UMSOM) scientists and physicians. This is the only external-beam radiation delivery system specifically designed to treat breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Radiation therapy's pivotal role in treating breast cancer featured at SABCS 2018
(American Society for Radiation Oncology) This year's San Antonio Breast Cancer Symposium (SABCS) features a record number of radiation oncology trials among its oral presentations. Today's General Session 4 (3:15-5:00 p.m. CT in Hall 3) will showcase five major studies designed to improve outcomes for the majority of breast cancer patients who receive radiation therapy to cure and/or provide relief from the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Profiling a killer in warm blood
(Weizmann Institute of Science) Israeli scientists and physicians develop a new technology for profiling the unique genetic makeup of myeloma tumor cells that will allow better diagnosis and treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Lymph node ratio may predict who lives and dies from oral cavity cancer
(University of Colorado Anschutz Medical Campus) Patients with lymph node ratio greater than 10 percent had about 2.5 times greater risk of cancer recurrence and 2.7 times greater risk of death than patients with LNR below 10 percent. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

New imaging tools that trace key breast cancer enzymes may help guide therapies
(University of Pennsylvania School of Medicine) A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers. New research from two studies conducted by researchers at the Perelman School of Medicine at the University of Pennsylvania, are presented on today at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Penn plastic surgeons perform world's first robotic bilateral breast reconstruction
(University of Pennsylvania School of Medicine) A team of surgeons from the Perelman School of Medicine at the University of Pennsylvania are the first in the world to use a surgical robot to assist with a bilateral free flap breast reconstruction, allowing patients to recover and be discharged more quickly and without the use of addictive narcotic painkillers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

What can a snowflake teach us about how cancer spreads in the body?
(University of Southern California) What can seashells, lightning and the coastline of Britain teach us about new drugs for cancer? The answer, according to a team of researchers at the USC Viterbi School of Engineering, may revolve around fractals, the infinitely complex patterns found in nature. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Accelerated PBI close but not equivalent to WBI to control ipsilateral breast tumor recurrence
(American Association for Cancer Research) Data from the NRG (NSABP B-39/RTOG 0413) trial indicated that ipsilateral breast tumor recurrence (IBTR) rates 10 years after treatment could not reject the hypothesis that accelerated partial breast irradiation (PBI) after lumpectomy was inferior to whole breast irradiation (WBI), according to a presentation at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 6, 2018 Category: International Medicine & Public Health Source Type: news

Three quarters of a Quebec population fall short of healthy eating guidelines
(Elsevier) In a web-based study reported in the Canadian Journal of Cardiology, more than three quarters of French-speaking adults in Quebec, Canada, fall short of meeting current dietary guidelines regarding consumption of fruits and vegetables, whole grains, sodium, and saturated fats. The authors recommend stronger, more impactful actions to support everyone in adopting healthier dietary habits to reduce the risk of chronic diseases such as heart disease, diabetes, and cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 6, 2018 Category: Biology Source Type: news

Tissue Stiffness is a "Mosh Pit ” Where Cancer Cells Thrive
Imagine being at a packed concert hall with a mosh pit full of dancers creating a wall against outsiders. When targeted drugs try to make their way toward a pancreas tumor, they encounter a similar obstacle in stiff tissue that surrounds and protects the cancer. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - December 6, 2018 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Ark launches stomach cancer blood test for early stage stomach cancer detection
Ark, a Singapore-based medtech enterprise focused on early cancer detection, has raised a record US$40 million in Series A funding. Ark ’s vision is “a world without late-stage cancer” and its mission is to eliminate late-stage cancer related death by 2048 through the introduction of accurate, affordable, and actionable cancer detection technologies. (Source: mobihealthnews)
Source: mobihealthnews - December 6, 2018 Category: Information Technology Source Type: news

TNBC Study of Capecitabine Mostly Disappoints, With One Exception TNBC Study of Capecitabine Mostly Disappoints, With One Exception
A study of adjuvant capecitabine in triple-negative breast cancer was largely negative, but disease-free and overall survival were improved in a subset of patients with the nonbasal-like phenotype.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - December 6, 2018 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Type 2 Diabetes Linked to Colorectal Cancer Risk in Men
Significant association for men, with positive but not statistically significant link seen for women (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 6, 2018 Category: Cancer & Oncology Tags: Endocrinology, Gastroenterology, Oncology, Journal, Source Type: news